Jonathan Schechter Pharma Cyte Biotech, Inc. (PMCB) insider trading activity

Jonathan Schechter is Director of PharmaCyte Biotech, Inc.. Currently has a direct ownership of 132,500 shares of PMCB, which is worth approximately $104,675. The most recent transaction as insider was on Dec 12, 2025, when has been sold 67,500 shares (Common Stock) at a price of $1.02 per share, resulting in proceeds of $68,850. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 133K

n/a 3M change

n/a 12M change

Total Value Held $104,675

JONATHAN SCHECHTER Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Dec 12 2025	SELL Payment of exercise price or tax liability	$68,850 $1.02 p/Share	67,500 Reduced 33.75%	132,500 Common Stock
Dec 12 2025	BUY Grant, award, or other acquisition	-	150,000 Added 42.86%	200,000 Common Stock

Also insider at

SNPX

Synaptogenix, Inc. Healthcare

Director

OBLG

Oblong, Inc. Technology

Director